Dr. Kenneth S. Shindler, MD

Dr. Shindler practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Shindler's NPI, 1063440071, was assigned on June 29, 2006. Dr. Shindler graduated from Washington University School of Medicine in 1999. Dr. Shindler holds Pennsylvania license MD421309.

Dr. Shindler's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Shindler's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Shindler is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Shindler to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shindler practices, 3 sites in all. Vendor and product names are available with a free account.

Neuro-ophthalmology is Dr. Shindler's primary specialty in the NPI Registry, under taxonomy code 207WX0109X. Dr. Shindler is licensed in Pennsylvania.

CMS data shows 78 Medicare services from Dr. Shindler across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $7,381 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Shindler in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high cholesterol, and 55% have arthritis. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shindler's median patient age at 62, with 61% women.

In 2024, Dr. Shindler wrote 37 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $358 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Shindler for performance year 2024, reported as part of a group. Dr. Shindler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 73 papers to Dr. Shindler, published from 2008 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Retinal Ganglion Cells, Mice, Inbred C57BL and Disease Models, Animal. Dr. Shindler has published most often in J Neuroophthalmol. Dr. Shindler's most frequent co-authors are Ahmara Gibbons Ross, MD, PhD, Madhura Anand Tamhankar, MD and Grant T. Liu, MD.

Dmand AI links Dr. Shindler to 2 clinical trials. Conditions studied include Optic Neuritis, Pseudotumor Cerebri and Intracranial Hypertension.

CMS Open Payments shows 2 general payments to Dr. Shindler from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $47.

Dr. Shindler graduated from Washington University School of Medicine in 1999.